Neurology News

Although it was well tolerated, the anti-amyloid antibody crenezumab did not reduce clinical decline in patients with Alzheimer's disease, researchers reported in JAMA Neurology.

Entrepreneurial opportunities for physicians are becoming more important than ever, according to a presenter at the Women in Medicine Summit.

A phase 3 trial that evaluated the safety and efficacy of the intrathecally administered antisense oligonucleotide tofersen reduced concentrations of superoxide dismutase 1 protein in patients with ALS who had mutations in the gene.

Fortunately, in recent years, migraine has gained wider public and provider recognition as a complex and serious, chronic neurological disease that can profoundly impact a person’s quality of life.

The FDA has approved Elucirem, a macrocyclic gadolinium-based contrast agent for those aged 2 years and older, for use in contrast-enhanced MRIs

PHILADELPHIA — In this video from Building a Successful Practice – Pennsylvania, Emily Ast, Esq., said asking questions up front when negotiating physician contracts ensures physicians commit to only providing expected services.

In this edition, FDA votes to support approval of ALS therapy; partnership offers military veterans access to psychedelics; epidural steroid injections as alternate pain management options and more.

Acupuncture was shown to be an effective treatment for anxiety in patients with Parkinson’s disease, researchers reported in JAMA Network Open.

CHICAGO — Two speakers at the Women in Medicine Summit announced an effort to lift up other women and reach “an equal playing field.”

The FDA and NIH announced the launch of the Critical Path for Rare Neurodegenerative Diseases, a public-private partnership aimed to advance the understanding of neurodegenerative diseases and the development of treatments.